Prevalence of Osteosarcopenic Obesity in Older Adults

Completed

• Conditions: Sarcopenia; Osteopenia; Obesity; Osteoporosis

• Registration Number: NCT04288401
• Lead Sponsor: Istanbul Medeniyet University

Brief Summary

Osteosarcopenic Obesity (OSO) is a syndrome characterized by the loss of bone and muscle in addition to increase in the fat tissue as a result of aging process. It is the latest point of impairment in the bone,muscle and adipose tissue in older adults. OSO, as the name suggests, is the combination of three syndrome frequently encountered in the elderly: osteopenia/osteoporosis, sarcopenia and obesity. The aims of study are to determine the prevalence of OSO syndrome in community-dwelling adults of Turkey and determine the possible factors regarding risk of falling in this population

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-25
• Study First Submitted: 2020-02-26
• Study First Submitted QC: 2020-02-26
• Study First Posted: 2020-02-28
• Primary Completion: 2020-03-31
• Study Completion: 2020-04-01
• Status Verified: 2020-05
• Last Update Submitted: 2020-05-16
• Last Update Posted: 2020-05-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 460

Inclusion Criteria

• Age of 65 or over
• Being had been examined for all the primary outcome measures (i.e. the results of primary outcomes must be in the patient's file)

Exclusion Criteria

• Severe cognitive dysfunction
• not being able to walk independently for 4 m

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
T score	1 hour	T scores of spine and femur neck examined with Dual X-Ray Absorptiometry. A T score\<-2,5 will be classified as osteoporosis while a T score between -1 and -2,5 will be counted as osteopenia
Muscle Strength	5 minutes	Measured by hand held dynamometer. The cut-off scores for man and woman are 27 kg and 16 kg, respectively
Muscle Performance	3 minutes	Tested by 4 meter walk test. If the gait speed is lower than 0,8 m/s, the test is positive.
Muscle Mass	2 minutes	Measured by bioimpedance analysis using Tanita TBF300. The cut-off scores for man and woman are 9,2 kg/m2 and 7,4 kg/m2, respectively
Obesity	2 minutes	The fat percentage and the Body Mass Index measured by bioimpedance analysis using Tanita TBF300 is recorded. For BMI, 30 kg/m2 and over is classified as obesity whereas fat percentage of %35 and %28 (woman and man, respectively) and over was classified as obese.

Secondary Outcome Measures

Name	Time	Method
Comorbidity	3 minutes	Using Charlson Comorbidity Index
History of falls	1 minutes	A patient's self stated history of falls will be considered as having a history of fall or not.

Trial Locations

Locations (1)

Goztepe Training and Research Hospital; 🇹🇷 Istanbul, Turkey